At a glance
- Originator Servier
- Class Antidepressants; Anxiolytics
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 07 Sep 2001 No-Development-Reported for Anxiety disorders in France (Unknown route)
- 07 Sep 2001 No-Development-Reported for Depression in France (Unknown route)
- 07 Jan 1997 Preclinical development for Depression in France (Unknown route)